These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26228524)

  • 1. Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.
    Vitucci D; Di Giorgio A; Napolitano F; Pelosi B; Blasi G; Errico F; Attrotto MT; Gelao B; Fazio L; Taurisano P; Di Maio A; Marsili V; Pasqualetti M; Bertolino A; Usiello A
    Neuropsychopharmacology; 2016 Feb; 41(3):916-27. PubMed ID: 26228524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.
    Li Z; Boules M; Williams K; Gordillo A; Li S; Richelson E
    Neurobiol Dis; 2010 Nov; 40(2):467-77. PubMed ID: 20659557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers.
    Deslauriers J; Larouche A; Sarret P; Grignon S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():156-64. PubMed ID: 23697796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
    Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A
    Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
    Blasi G; Napolitano F; Ursini G; Di Giorgio A; Caforio G; Taurisano P; Fazio L; Gelao B; Attrotto MT; Colagiorgio L; Todarello G; Piva F; Papazacharias A; Masellis R; Mancini M; Porcelli A; Romano R; Rampino A; Quarto T; Giulietti M; Lipska BK; Kleinman JE; Popolizio T; Weinberger DR; Usiello A; Bertolino A
    Am J Psychiatry; 2013 Aug; 170(8):868-76. PubMed ID: 23598903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
    Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
    Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models.
    Napolitano F; D'Angelo L; de Girolamo P; Avallone L; de Lange P; Usiello A
    Neuroscience; 2018 Aug; 384():419-428. PubMed ID: 29857029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia.
    Zhang C; Ni P; Liu Y; Tian Y; Wei J; Xiang B; Zhao L; Li X; Ma X; Deng W; Guo W; Ni R; Zhang Y; Wang Q; Huang H; Zhang N; Li T
    Neurosci Bull; 2020 Feb; 36(2):97-109. PubMed ID: 31388929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
    Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
    J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function.
    Liu YL; Fann CS; Liu CM; Chen WJ; Wu JY; Hung SI; Chen CH; Jou YS; Liu SK; Hwang TJ; Hsieh MH; Chang CC; Yang WC; Lin JJ; Chou FH; Faraone SV; Tsuang MT; Hwu HG
    Biol Psychiatry; 2008 Nov; 64(9):789-96. PubMed ID: 18571626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult mice with reduced Nurr1 expression: an animal model for schizophrenia.
    Rojas P; Joodmardi E; Hong Y; Perlmann T; Ogren SO
    Mol Psychiatry; 2007 Aug; 12(8):756-66. PubMed ID: 17457314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects.
    Keller S; Errico F; Zarrilli F; Florio E; Punzo D; Mansueto S; Angrisano T; Pero R; Lembo F; Castaldo G; Usiello A; Chiariotti L
    Psychiatry Res; 2014 Dec; 220(3):1147-50. PubMed ID: 25219617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.
    Healy DJ; Haroutunian V; Powchik P; Davidson M; Davis KL; Watson SJ; Meador-Woodruff JH
    Neuropsychopharmacology; 1998 Oct; 19(4):278-86. PubMed ID: 9718591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
    Meyer-Lindenberg A; Miletich RS; Kohn PD; Esposito G; Carson RE; Quarantelli M; Weinberger DR; Berman KF
    Nat Neurosci; 2002 Mar; 5(3):267-71. PubMed ID: 11865311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.
    Bertolino A; Fazio L; Caforio G; Blasi G; Rampino A; Romano R; Di Giorgio A; Taurisano P; Papp A; Pinsonneault J; Wang D; Nardini M; Popolizio T; Sadee W
    Brain; 2009 Feb; 132(Pt 2):417-25. PubMed ID: 18829695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular brain imaging and the neurobiology and genetics of schizophrenia.
    Heinz A; Romero B; Gallinat J; Juckel G; Weinberger DR
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S152-7. PubMed ID: 14677072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
    Meador-Woodruff JH; Haroutunian V; Powchik P; Davidson M; Davis KL; Watson SJ
    Arch Gen Psychiatry; 1997 Dec; 54(12):1089-95. PubMed ID: 9400344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
    Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
    Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: examining synapsin II in the pathophysiology of schizophrenia.
    Dyck BA; Beyaert MG; Ferro MA; Mishra RK
    Schizophr Res; 2011 Aug; 130(1-3):250-9. PubMed ID: 21689907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.